The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPATH.L Regulatory News (PATH)

  • There is currently no data for PATH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Further re the Acquisition of 75% of DT Ultravert

5 Nov 2020 07:00

RNS Number : 3105E
Path Investments plc
05 November 2020
 

 

Path Investments plc("Path" or the "Company")

 

Extension of and Amendment to Agreement for the Acquisition of 75% of DT Ultravert from Zoetic International plc

 

Path Investments plc (TIDM: PATH), the energy and natural resources investment company, is pleased to announce the extension of, and certain amendments to, its binding agreement with Zoetic International plc ("Zoetic") for the acquisition of its 75% ownership of DT Ultravert ("DTU").

 

As announced on 1 October 2020, Path has secured agreement for the purchase of 25% of DTU from Diversion Technologies LLC ("Diversion") and therefore the conclusion of the acquisition from Zoetic will unify DTU in one party's ownership for the first time. Path considers this will be a key factor in the successful marketing of DTU going forward.

 

The Company has previously announced that it is proceeding with preparation for publication of a prospectus relating to its acquisition of 100% of DTU from both Zoetic and Diversion and readmission of Path's ordinary shares to the standard segment of the Official List maintained by the Financial Conduct Authority and to trading on the Main Market of the London Stock Exchange ("Re-admission"). This is progressing, but to accommodate the time required to complete the matters associated with the Re-admission, the Company and Zoetic have agreed to extend the long stop date within the agreement. No such extension is required at this time for the agreement with Diversion.

 

In addition, Path and Zoetic have taken the opportunity to amend the consideration and structure of the transaction to match that agreed with Diversion pro-rata.

 

Firstly, in order to simplify the transaction, the Kansas assets will now be retained by Zoetic and accordingly they no longer form part of the transaction. The Company has today agreed with GasRock Limited that the conditional agreement announced by the Company on 5 October 2020 for their purchase of the Kansas assets is cancelled with immediate effect, at no cost to either party.

 

Secondly, the consideration for the acquisition of the 75% of DTU from Zoetic has been adjusted and will now be satisfied by the issue by Path to Zoetic of 30,000,000 ordinary shares in Path on Re-admission, together with the issue of 15,000,000 warrants to subscribe for ordinary shares in Path at any time from the first to the third anniversaries following completion of the acquisition at an exercise price of 1.5 pence per ordinary share. In return, Zoetic has agreed that no royalty payments will be made in respect of revenue earned by Path from DTU.

 

Completion of the transactions with Zoetic and Diversion are subject to a number of items, including the publication of a prospectus by Path prepared in accordance with the Prospectus Regulation Rules made under section 73A of the Financial Services and Markets Act 2000 (as amended) and approved by the UK Financial Conduct Authority under section 87A of Financial Services and Markets Act 2000 (as amended) and Re-admission.

 

Commenting, Christopher Theis CEO of Path, said: "We are pleased to have agreed the extension and amendment of our transaction with Zoetic. We now have a more balanced and simplified transaction structure which meets the needs of all parties and we look forward to completion of the transaction shortly. The removal of the ongoing royalty in return for the restructured consideration and retention of the Kansas assets by Zoetic creates a cleaner structure and one which is potentially more valuable to Path over the long term."

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. The public disclosure of this inside information was delayed pursuant to Article 17(4) MAR.

 

For further information please contact:

Path Investments plc

C/O IFC

Christopher Theis

IFC Advisory Limited (Financial PR & IR)

020 3934 6630

Tim Metcalfe

Zach Cohen

Grant Thornton UK LLP (Financial Adviser)

Jamie Barklem

020 7865 2692

Harrison Clarke

020 7184 4384

Keith, Bayley, Rogers & Co. Limited (Broker)

Brinsley Holman

07776 30 22 28

Graham Atthill-Beck

07506 43 41 07

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FURBIBMTMTJMTMM
Date   Source Headline
7th Jul 20202:00 pmRNSUpdate on Acquisition
22nd Jun 20204:45 pmRNSFurther re Application for Lifting of Suspension
17th Jun 20207:00 amRNSFinancial Adviser Appointment
17th Jun 20207:00 amRNSDirector/PDMR Shareholding
12th Jun 20207:00 amRNSFundraising & Lifting of Suspension Application
27th May 20207:00 amRNSExpiry of Share Purchase Agreement with FineGems
27th May 20207:00 amRNSAcquisition of DTU and Kansas Nitrogen Reserves
20th May 202012:20 pmRNSResult of AGM
18th May 202011:59 amRNSChange of Registered Office
24th Apr 20207:00 amRNSNotice of AGM
24th Apr 20207:00 amRNSAppointment of Corporate Broker
21st Jan 20203:39 pmRNSUpdate and resignation of director
26th Sep 201912:44 pmRNSInterim Results
20th Aug 20197:00 amRNSNew Corporate Website
19th Aug 20197:00 amRNSProposed Acquisition of FineGems Extraction
28th Jun 20197:00 amRNSFinal Results for the Year Ended 31 December 2018
17th Jun 20199:52 amRNSCompany update
13th Mar 20197:00 amRNSWithdrawal from Proposed Transaction
1st Mar 20193:13 pmRNSUpdate on Heads of Agreement
1st Feb 20197:00 amRNSSale of Turkish interests
18th Jan 20197:01 amRNSInterim Results for the six months to 30 June 2018
18th Jan 20197:00 amRNSHeads of Agreement
5th Nov 20187:00 amRNSWithdrawal from proposed Farm-in Agreement
10th Oct 20184:00 pmRNSSchedule One Update - Path Investments Plc
25th Sep 20189:45 amRNSSch 1 Update - Path Investments Plc
4th Sep 20187:30 amRNSSch 1 Update - Path Investments Plc
28th Aug 201811:38 amRNSResult of AGM
6th Aug 20185:30 pmRNSSchedule One - Path Investments Plc
3rd Aug 20187:00 amRNSNotice of AGM
30th Jul 20187:00 amRNSProposed Placing to raise £10 million
29th Jun 20187:00 amRNSGeneral Meeting Statement
4th Jun 20183:49 pmRNSAnnual Report and Notice of GM (Replacement)
4th Jun 20182:13 pmRNSAvailability of Annual Report and Notice of AGM
4th Jun 20182:08 pmRNSAnnual Results for the year ended 31 December 2017
25th May 20182:57 pmRNSCompany Update
28th Mar 20187:00 amRNSUpdate re Intended Standard Listing cancellation
8th Mar 20187:00 amRNSUpdate re cancellation of standard listing
20th Feb 20187:00 amRNSUpdate on Well A-EZ Z4 (2)
7th Feb 20182:10 pmRNSUpdate re Proposed Farm-in Agreement
19th Jan 20184:31 pmRNSIntended cancellation of Standard Listing
15th Dec 20177:30 amRNSSuspension Path Investments plc
15th Dec 20177:00 amRNSFarm-in Agreement and Temporary Suspension
25th Sep 20177:00 amRNSInterim Results
26th Jul 20177:00 amRNSDirector/PDMR Shareholding
8th Jun 20177:00 amRNSHolding(s) in Company
5th Jun 20174:10 pmRNSHolding(s) in Company
23rd May 20173:47 pmRNSHolding(s) in Company
22nd May 201712:11 pmRNSResult of AGM
15th May 201710:29 amRNSPath Investments engagement via Vox Markets
11th May 20177:00 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.